INBS raises $1.77M via Series E warrant exercise; issues Series G warrants at $4.50

INTELLIGENT BIO SOLUTIONS INC.

Existing warrant holders exercised 606,064 shares at $2.9232 for gross proceeds of ~$1.77M.
Holders receive one Series G warrant per exercised warrant, exercisable at $4.50 for 5.5 years.
Company to use net proceeds for working capital and general corporate purposes.
Ladenburg Thalmann acted as placement agent; fees include 8% cash fee and 5% warrant coverage.
Resale registration statement for Series G shares must be filed within 30 days.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

INTELLIGENT BIO SOLUTIONS INC. entered into Agreements with certain accredited and institutional holders valued at approximately $1.77 million (effective 2024-02-04).

Action: entry
Agreement: equity purchase
Counterparty: certain accredited and institutional holders
Value: approximately $1.77 million
Effective: 2024-02-04

Exact text from the filing

On February 4, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into warrant inducement agreements (the “Agreements”) with certain accredited and institutional holders (collectively, the “Holders”) of the Company’s outstanding Series E Warrants issued on October 4, 2023

View on SEC.gov

Browse all material agreements →

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-005267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.